Literature DB >> 24534283

Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol.

Human Mousavi Fatemi1, Biljana Popovic-Todorovic2, Peter Humaidan3, Shahar Kol4, Manish Banker5, Paul Devroey6, Juan Antonio García-Velasco7.   

Abstract

OBJECTIVE: To report two cases with GnRH agonist triggering and a freeze-all approach in a GnRH antagonist protocol resulting in the development of severe ovarian hyperstimulation syndrome (OHSS), requiring hospitalization and peritoneal drainage.
DESIGN: Two case reports.
SETTING: A tertiary referral center and an obstetrics and gynecology department of a hospital. PATIENT(S): Case 1 and case 2: severe OHSS with abdominal distension, ascites development, and hemoconcentration. INTERVENTION(S): Case 1 and case 2: diagnosed by clinical, hematologic, and ultrasound findings. Hospitalization, IV infusion, and peritoneal drainage. MAIN OUTCOME MEASURE(S): Symptomatic treatment and prevention of further complication. RESULT(S): Complete recovery. CONCLUSION(S): Two cases of severe OHSS after GnRH agonist trigger in a GnRH antagonist protocol without the administration of any hCG for luteal-phase support. Clinicians have to be aware that even the sequential approach to ovarian stimulation with a freeze-all attitude does not completely eliminate OHSS in all patients.
Copyright © 2014 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GnRH agonist triggering; GnRH antagonist; freeze-all; ovarian hyperstimulation syndrome

Mesh:

Substances:

Year:  2014        PMID: 24534283     DOI: 10.1016/j.fertnstert.2014.01.019

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  41 in total

1.  Does freeze all policy eliminate OHSS??? "It ain't necessarily so…".

Authors:  Zeev Blumenfeld
Journal:  J Assist Reprod Genet       Date:  2015-09-07       Impact factor: 3.412

2.  What is the best predictor of severe ovarian hyperstimulation syndrome in IVF? A cohort study.

Authors:  Theoni B Tarlatzi; Christos A Venetis; Fabienne Devreker; Yvon Englert; Anne Delbaere
Journal:  J Assist Reprod Genet       Date:  2017-07-14       Impact factor: 3.412

3.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

4.  Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience.

Authors:  Talya Shaulov; Maria P Vélez; Karen Buzaglo; Simon J Phillips; Isaac Jacques Kadoch
Journal:  J Assist Reprod Genet       Date:  2015-06-04       Impact factor: 3.412

5.  GnRH Antagonist Cetrorelix Administration Before hCG for Protection of Ovarian Hyperstimulation Syndrome.

Authors:  Sherif A Hebisha; Banan A Aboelazm; H N Sallam
Journal:  J Obstet Gynaecol India       Date:  2016-11-29

Review 6.  Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment.

Authors:  Ali Abbara; Sophie A Clarke; Waljit S Dhillo
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

7.  Why more is less and less is more when it comes to ovarian stimulation.

Authors:  Zeev Blumenfeld
Journal:  J Assist Reprod Genet       Date:  2015-10-19       Impact factor: 3.412

Review 8.  The state of "freeze-for-all" in human ARTs.

Authors:  Natalia Basile; Juan A Garcia-Velasco
Journal:  J Assist Reprod Genet       Date:  2016-09-14       Impact factor: 3.412

9.  Abnormal implantation after fresh and frozen in vitro fertilization cycles.

Authors:  Erica T Wang; Anupama S Q Kathiresan; Catherine Bresee; Naomi Greene; Carolyn Alexander; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2017-04-19       Impact factor: 7.329

10.  Rare genetic variants potentially involved in ovarian hyperstimulation syndrome.

Authors:  Katrien Stouffs; Sari Daelemans; Samuel Santos-Ribeiro; Sara Seneca; Alexander Gheldof; Ali Sami Gürbüz; Michel De Vos; Herman Tournaye; Christophe Blockeel
Journal:  J Assist Reprod Genet       Date:  2018-11-27       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.